Pfizer to settle with Apotex over Lipitor patents
This article was originally published in Scrip
Executive Summary
Pfizerhas agreed to settle with the Canadian drugmaker Apotexover a patent dispute relating to its top-selling Lipitor (atorvastatin calcium).